Stimcell Energetics (STME) Cash from Operations (2011 - 2026)
Stimcell Energetics' (STME) quarterly Cash from Operations came in at 86290.0 in Q1 2026, down 97.39% year-on-year from 3303199.33 in Q1 2025, and down 16.39% quarter-over-quarter from 74138.0 in Q4 2025.
Stimcell Energetics (STME) Cash from Operations (2011 - 2026) Analysis & Trends
Stimcell Energetics' Cash from Operations history runs 14 years deep, the most recent figure standing at 86290.0 for Q1 2026.
- On a quarterly basis, Cash from Operations fell 97.39% year-over-year to 86290.0 in Q1 2026; TTM through Feb 2026 was 327018.0, a 183.33% decrease from a year earlier, with the FY2025 full-year figure at 141600.0, up 2.95% from the prior year.
- Cash from Operations retreated to 86290.0 in Q1 2026 per STME's latest filing, from 74138.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 16519.0 in Q4 2024 and bottomed at 108142.0 in Q3 2025.
- The 5-year median for Cash from Operations is 58448.0 (2025), against an average of 59448.18.
- Across the five-year window, Cash from Operations soared 72.91% in 2023 and tumbled 371.89% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 67566.0 in 2022, then soared by 47.71% to 35328.0 in 2023, then surged by 53.24% to 16519.0 in 2024, then slumped by 348.8% to 74138.0 in 2025, then retreated by 16.39% to 86290.0 in 2026.
- Per Business Quant, the three latest STME Cash from Operations figures stand at 86290.0 (Q1 2026), 74138.0 (Q4 2025), and 108142.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | -86,290.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -86,290.00 |
| Feb 28, 2026 | -86,290.00 |
| Nov 30, 2025 | -74,138.00 |
| Nov 30, 2025 | -74,138.00 |
| Aug 31, 2025 | -108,142.00 |
| Aug 31, 2025 | -108,142.00 |
| May 31, 2025 | -58,448.00 |
| May 31, 2025 | -58,448.00 |
| Feb 28, 2025 | -43,716.00 |
| Feb 28, 2025 | -43,716.00 |
| Nov 30, 2024 | -16,519.00 |
| Nov 30, 2024 | -16,519.00 |
| Aug 31, 2024 | -22,917.00 |
| Aug 31, 2024 | -22,917.00 |
| May 31, 2024 | -32,268.00 |
| May 31, 2024 | -32,268.00 |
| Feb 29, 2024 | -37,945.00 |
| Feb 29, 2024 | -37,945.00 |
| Nov 30, 2023 | -35,328.00 |
| Nov 30, 2023 | -35,328.00 |